Drug Device Combination Market Share, Business Analysis, Explosive Growth Opportunities, Regional Analysis by Size 2020-2030

 

Drug Device Combination Market

Market Highlights

Following a careful analysis of the latest trends, Market Research Future (MRFR) in its latest report states that the Drug Device Combination Market is expected to reach USD 251.90 Billion by 2030 at 7.2% CAGR during the forecast period 2022-2030.

Companies Profiled

The leading participants in the worldwide drug device combination products are

Abbott Laboratories, AlloSource, Biomet Orthopedics, Inc., Wright Medical Group, Inc., Biotronik, Boston Scientific Corporation, St. Jude Medical Inc, 3M Inc., Covidien Ltd, Biometrix Medical, Stryker Corporation, C.R. BARD, Zimmer Holding, Inc., Cook Critical Care, Inc., Smith & Nephew Plc

Growth Drivers and Top Barriers

drug device combination products allows early diagnosis along with shorter treatment duration in most of the surgical procedures. The surge in the demand is also the result of various other benefits including minimal pain, improved safety, cost efficiency, high efficacy, speedy recovery, and decreased hospital stay owing to these devices. The growing number of regulatory healthcare authorities defining the strict protocols for premarket authorizations is projected to prompt the manufacturers in getting approvals for their products. For instance, the United States (U.S.) FDA had come up with the lean management process mapping approach for developing a more streamlined, cohesive, collaborative and systematic system to analyze the said products. The stringent safety guidelines as well as recommendations by the authorities across the globe are poised to raise the adoption rate of these products in the coming years, stimulating the growth of the overall market.

Market Segmentation

The worldwide Drug Device Combination Market has been segmented on the basis of product, application, and end user.

·         In terms of product, the market can be broken down into catheter, advanced wound care products, and others.

·         Application-wise segments in the market are coronary angioplasty, tachycardia management, non-cardiovascular treatments, peripheral arterial disease (pad), bone treatment, antimicrobial applications, wound care, ophthalmic treatment, and others.

·         The end users covered in the report include hospitals & clinics, ambulatory centers, and academic & research organization, and others.

Regional Segmentation

The Americas, Europe, Asia Pacific and the Middle East & Africa are the key regions in the global drug device combination market.

The Americas has left other regions in the lurch with the dominant share of the overall market, due to the growing prevalence of cardiovascular diseases coupled with the existence of prominent players based in the region. Moreover, appropriate reimbursement policies, elevated spending on healthcare, and a well-established healthcare industry in the United States (U.S.) and Canada are identified as the crucial drivers for the drug device combination market in the region.

The data experts report that Europe had been at the second position in the global drug device combination market in 2017, with factors like the presence of a highly-developed healthcare infrastructure, surging awareness about the devices and the massive contribution of developed nations in the region backing the market growth. On top of that, a humungous patient pool is powering the regional market further.

Expanding at the fastest growth rate as reported in 2017, Asia Pacific is launching ahead backed by the growing penetration of prominent vendors into the region, booming healthcare sector and rising support of the government for foreign investments. A report furnished by the Indian Brand Equity Foundation in 2017 states that the Indian healthcare industry was predicted to expand at a CAGR of 22.87, with further predictions of it set to reach the valuation of USD 280 billion by the year 2020. These favorable numbers are expected to subsequently work in favor of the drug device combination market in the following years.

Finally, the Middle East and Africa accounts for the smallest share in the worldwide drug device combination market because of the presence of poor countries as well as low per capita income, particularly in the Africa region. The regional market is forecasted to be governed by the Middle East as a result of the growing government funding in a bid to expand the healthcare industry, in addition to the presence of flourishing nations such as the United Arab Emirates, Dubai, Saudi Arabia, among others.

Industry News

May 2019: Medtronic PLC MDT has recently launched the Telescope guide extension catheter that will offer support as well as access to the distal lesions. This product launch reflects the company’s entry marks the company’s entry into the guide extension catheter market and subsequently the drug device combination market.

Related Report-

·         Flow Cytometry Market Research Report – Forecast to 2027      

·         CBD Hemp Oil Market Research Report – Forecast to 2027          

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Comments

Post a Comment

Popular posts from this blog

Ayurvedic Products Market Outlook, Trend, Growth and Share Estimation Analysis and Forecast 2020-2030

Image
  Global Ayurvedic Products Market Overview Ayurvedic Products are generally used in personal care and healthcare products. Ayurvedic products originated from India, and thus, the concentration of ayurvedic product suppliers is the highest in the country. According to the latest research reports Due to growing inclination for natural treatment, the Ayurvedic Products Market , size is projected to reach USD 28830.5 Million by 2030 at 12.3% CAGR. Many factors are influencing a significant rise in the growth rate between during forecast periods. Increasing adoption of traditional methods for medicinal purposes is observed to cause a significant boost in the global Ayurvedic Products Market With a rise in the working woman population, rising disposable income, and a growing inclination towards chemical free and herbal cosmetics are some of the primary factors contributing to the ascension of the global ayurvedic market. Apart from personal care, ayurvedic healthcare products are...
Read more

Pain Management Devices Market Set To Exhibit Strong Growth, Valuable Research Factors and Industry Forecast to 2030

Image
  Pain Management Devices Market – Overview The Pain Management Devices Market can anticipate expansion at a rate of 7.12% from 2020 to 2030, believes MRFR (Market Research Future). Progress in technology and better research capabilities have led to the development of devices that can control pain with limited use of drugs. Focused Market reports connected to the healthcare sector among others lately have been made available by Market Research Future which publishes a report on this sector. The development of pain management devices has been useful to control pain in a wide range of ailments. The level of relief from pain that is experienced, is one of the major driving factors for the industry, as patients who use such devices are prone to chronic pain daily. Cancer patients and the geriatric population are among the major user segments for the pain management devices as medication alone may not be sufficient to provide pain relief in their situation. The industry is antici...
Read more

Breast Cancer Market 2022-2027 Worldwide Demand and Growth Analysis Report 2022-2027

Image
  Breast Cancer is the second-most common type of cancer in women and one of the paramount concerns, globally. According to WHO, every year, around 200,000 new cases get registered, and the digits are continuously increasing. Many statistics show that breast cancer is more prevalent in developed countries such as the UK, the US, and Australia as their women are more prone to acquire the disease. This doesn’t mean that women from developing countries like India and China are out of breast cancer’s radar. On the contrary, they are more vulnerable than women from developed regions. Unavailability of proper treatment due to the lack of funds and awareness towards the government’s programs is killing them more than breast cancer can. Advancements in medical science and biotechnology have improved the outlook of diagnosis. However, the recovery is still challenging as survivors adjust to the scars that remain mentally and physically. Surprisingly, the Breast Cancer Market is still a...
Read more